Skip to main content
Top
Published in: Critical Care 1/2004

01-02-2004 | Poster presentation

Sputum concentration of amikacin varies with nebulizer efficiency measured in vitro in patients on mechanical ventilators

Authors: P Dequin, E Mercier, C Valat, R Fishman, J Fink, N Smith, K Gibbons, P Diot

Published in: Critical Care | Special Issue 1/2004

Login to get access

Excerpt

Evaluation of the clinical utility of aerosolized antibiotics in patients with ventilator-associated pneumonia has been hampered by the inefficiency of available nebulizers. The Aerogen pulmonary drug delivery system (APD) is in development for high-efficiency lung deposition of novel therapies in mechanically ventilated patients. We compared delivery of amikacin (AMIK) via APD vs the the Aeroneb Pro (AP), and vs the AirLife™ Misty Neb™ (MN), in mechanically ventilated patients. We wanted to determine how AMIK concentrations in the sputum relate to device efficiency previously determined in vitro [1]. …
Literature
1.
go back to reference Fink JB, Uster P, Fishman R: In Vitro Evaluation of Aerosol Delivery of Amikacin During Mechanical Ventilation Baltimore, MD: International Society of Aerosol Medicine 2003. Fink JB, Uster P, Fishman R: In Vitro Evaluation of Aerosol Delivery of Amikacin During Mechanical Ventilation Baltimore, MD: International Society of Aerosol Medicine 2003.
Metadata
Title
Sputum concentration of amikacin varies with nebulizer efficiency measured in vitro in patients on mechanical ventilators
Authors
P Dequin
E Mercier
C Valat
R Fishman
J Fink
N Smith
K Gibbons
P Diot
Publication date
01-02-2004
Publisher
BioMed Central
Published in
Critical Care / Issue Special Issue 1/2004
Electronic ISSN: 1364-8535
DOI
https://doi.org/10.1186/cc2696

Other articles of this Special Issue 1/2004

Critical Care 1/2004 Go to the issue